background image

Clinical Trials In Ohio

Discover hundreds of clinical trials in Ohio.
Search clinical trials in Ohio by city, condition or phase.

e.g. Respiratory Diseases
OhioHealthy volunteers: No

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

Recruiting
PHASE3

Sponsor:

AbbVie

Location:

West Chester, Avon Lake, Cincinnati, Indianapolisshow 42 more

Code:

NCT04777357

Conditions

Depression

Bipolar I Disorder

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

Cariprazine

Placebo

Academic-Community EPINET (AC-EPINET)

Recruiting

Sponsor:

Indiana University

Location:

Columbus, Ann Arbor, Indianapolis, Rochestershow 2 more

Code:

NCT04497857

Conditions

Schizophrenia

Schizoaffective Disorder

Schizophreniform Disorders

Major Depression with Psychotic Features

Bipolar Disorder with Psychotic Features

Eligibility Criteria

Sex: All

Age: 16 - 35

Healthy Volunteers: Not accepted

Interventions

Coordinated Specialty Care (CSC)

B-Cell Targeted Carfilzomib Desensitization

Recruiting
PHASE1

Sponsor:

E. Steve Woodle

Location:

Cincinnati

Code:

NCT02442648

Conditions

Transplants and Implants

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Carfilzomib

Rituximab

A Study Evaluating APG777 in Atopic Dermatitis

Recruiting
PHASE2

Sponsor:

Apogee Therapeutics, Inc.

Location:

Mason, Boardman, Detroit, Pittsburghshow 27 more

Code:

NCT06395948

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

APG777

Placebo

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

Recruiting
PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Springfield, Akron, Kettering, Clevelandshow 147 more

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer

Recruiting
PHASE1
PHASE2

Sponsor:

Margaret Gatti-Mays

Location:

Columbus

Code:

NCT06026657

Conditions

Anatomic Stage IV Breast Cancer AJCC v8

HER2-Negative Breast Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Gemcitabine

Magnetic Resonance Imaging

Naxitamab

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Columbus, Akron, Dayton, Clevelandshow 99 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab

Recruiting
PHASE2

Sponsor:

Replimune Inc.

Location:

Cincinnati, Louisville, Rochester, Durhamshow 20 more

Code:

NCT03767348

Conditions

Cancer

Melanoma (Skin)

Mismatch Repair Deficiency

Microsatellite Instability

Non-melanoma Skin Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RP1

nivolumab

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

Sponsor:

Novartis Pharmaceuticals

Location:

Columbus, Akron, Cleveland, Cincinnatishow 44 more

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma

Recruiting
PHASE3

Sponsor:

GlaxoSmithKline

Location:

Dublin, Cincinnati, Windsor, Pittsburghshow 35 more

Code:

NCT06261957

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Salbutamol HFA-134a

Salbutamol HFA-152a

Popular cities in Ohio

With a robust healthcare network, renowned medical research centers, and innovative treatments, Ohio is a leading destination for a wide range of clinical trials. Institutions such as the Cleveland Clinic, Ohio State University Wexner Medical Center, University Hospitals Cleveland Medical Center, and Nationwide Children’s Hospital are at the forefront of these studies.

Why choose Ohio for clinical trials?

Common conditions studied in Ohio

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Ohio